Correlation Between Biotechnology Fund and Driehaus Multi-asset

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Driehaus Multi-asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Driehaus Multi-asset into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Fund Class and Driehaus Multi Asset Growth, you can compare the effects of market volatilities on Biotechnology Fund and Driehaus Multi-asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Driehaus Multi-asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Driehaus Multi-asset.

Diversification Opportunities for Biotechnology Fund and Driehaus Multi-asset

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Biotechnology and Driehaus is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Driehaus Multi Asset Growth in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Driehaus Multi Asset and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Driehaus Multi-asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Driehaus Multi Asset has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Driehaus Multi-asset go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Driehaus Multi-asset

Assuming the 90 days horizon Biotechnology Fund is expected to generate 1.25 times less return on investment than Driehaus Multi-asset. In addition to that, Biotechnology Fund is 1.24 times more volatile than Driehaus Multi Asset Growth. It trades about 0.06 of its total potential returns per unit of risk. Driehaus Multi Asset Growth is currently generating about 0.09 per unit of volatility. If you would invest  1,528  in Driehaus Multi Asset Growth on September 3, 2024 and sell it today you would earn a total of  190.00  from holding Driehaus Multi Asset Growth or generate 12.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Fund Class  vs.  Driehaus Multi Asset Growth

 Performance 
       Timeline  
Biotechnology Fund Class 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong technical and fundamental indicators, Biotechnology Fund is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Driehaus Multi Asset 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Driehaus Multi Asset Growth are ranked lower than 15 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Driehaus Multi-asset may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Biotechnology Fund and Driehaus Multi-asset Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Fund and Driehaus Multi-asset

The main advantage of trading using opposite Biotechnology Fund and Driehaus Multi-asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Driehaus Multi-asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Driehaus Multi-asset will offset losses from the drop in Driehaus Multi-asset's long position.
The idea behind Biotechnology Fund Class and Driehaus Multi Asset Growth pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance